1

Daratumumab 945721-28-8: A Deep Dive into its Properties

945721-28-8570324
The drug identified as 945721-28-8 represents a groundbreaking therapeutic agent, specifically designed to target CD38, an antigen found widely the surface of immune cells. Its mechanism of action involves multiple https://www.targetmol.com/compound/daratumumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story